Safety and Pharmacokinetic Comparison of Sildenafil ODF and FCT Formulations in Healthy Korean Volunteers

NCT01769638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SPO1101
DRUG: SPO1101D

Sponsor

Seoul Pharma Co., Ltd.